MG-132 100mg 100mg | Purity Not Available
Adooq Bioscience
MG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier PageMG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier PageMG-132 is a potent cell-permeable inhibitor of proteasome (IC50 = 100 nM) and calpain (IC50 = 1.2 ??M).
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageTubastatin A HCl is a potent HDAC inhibitor that demonstrates over more selectivity than all other HDAC isoforms (IC50s >16 uM), excluding HDAC8 (IC50 = 0.9 M).
More Information Supplier PageAR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
More Information Supplier PageAR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
More Information Supplier PageAR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
More Information Supplier PageAR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
More Information Supplier PageAR-42 is a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit.
More Information Supplier PageLY2603618 is a chk2 inhibitor that binds to and inhibits the activity of chk2, which may prevent the repair of DNA caused by DNA-damaging agents.
More Information Supplier Page